JUNO THERAPEUTICS, INC.

SEATTLE, WA How do I update this listing?

Juno Therapeutics is based out of Seattle. Juno Therapeutics Inc operates as a clinical-stage biotechnology company. The Company focuses on developing immunotherapies for cancer and other research services.Whalewisdom has at least 156 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2017-10-05. The notice included securities offered of Equity

Create Alert

Contact Info

juno therapeutics, inc.
400 DEXTER AVENUE NORTH, SUITE 1200
SEATTLE WA    98109

Business Phone: 2065821600
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2017-10-05 D BIOTECHNOLOGY Equity 31,091,407 31,091,407 0
2017-06-29 D/A BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security INDEFINITE 898,495,324 INDEFINITE
2016-07-06 D/A BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security INDEFINITE 896,803,493 INDEFINITE
2015-07-14 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security INDEFINITE 849,803,496 INDEFINITE
2014-08-14 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security 133,734,641 85,499,985 48,234,656
2014-05-08 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security 97,000,000 28,423,971 68,576,029
2013-12-26 D BIOTECHNOLOGY Equity 7,145,909 6,667,672 478,237
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ANTHONY EVNIN subscription required
    DIRECTOR
BERNARD CASSIDY subscription required
    EXECUTIVE OFFICER
HAL BARRON subscription required
    DIRECTOR
HANS BISHOP subscription required
    EXECUTIVE OFFICER DIRECTOR PROMOTER
HOWARD PIEN subscription required
    DIRECTOR
HYAM LEVITSKY subscription required
    EXECUTIVE OFFICER
JAY FLATLEY subscription required
    DIRECTOR
LARRY COREY subscription required
    DIRECTOR
MARC TESSIER-LAVIGNE subscription required
    DIRECTOR
MARK FROHLICH subscription required
    EXECUTIVE OFFICER
MARY AGNES WILDEROTTER subscription required
    DIRECTOR
RICHARD KLAUSNER subscription required
    DIRECTOR PROMOTER
RICK KLAUSNER subscription required
    DIRECTOR PROMOTER
ROBERT AZELBY subscription required
    EXECUTIVE OFFICER
ROBERT NELSEN subscription required
    DIRECTOR PROMOTER
RUPERT VESSEY subscription required
    DIRECTOR
STEVEN HARR subscription required
    EXECUTIVE OFFICER
SUNIL AGARWAL subscription required
    EXECUTIVE OFFICER
THOMAS DANIEL subscription required
    DIRECTOR

Elevate your investments